AC
Armistice Capital’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-490,868
| Closed | -$20.4M | – | 261 |
|
|
2024
Q2 | $20.4M | Buy |
+490,868
| New | +$20.4M | 0.26% | 63 |
|
|
2023
Q4 | – | Sell |
-529,613
| Closed | -$30.7M | – | 306 |
|
|
2023
Q3 | $30.7M | Buy |
529,613
+129,613
| +32% | +$7.52M | 0.47% | 39 |
|
|
2023
Q2 | $25.6M | Buy |
+400,000
| New | +$25.6M | 0.37% | 50 |
|
|
2022
Q4 | – | Sell |
-600,000
| Closed | -$42.7M | – | 200 |
|
|
2022
Q3 | $42.7M | Sell |
600,000
-556,000
| -48% | -$39.5M | 0.74% | 34 |
|
|
2022
Q2 | $89K | Sell |
1,156,000
-240,000
| -17% | -$18.5K | 1.55% | 12 |
|
|
2022
Q1 | $102M | Sell |
1,396,000
-928,000
| -40% | -$67.8M | 1.97% | 7 |
|
|
2021
Q4 | $145M | Sell |
2,324,000
-32,000
| -1% | -$2M | 2.37% | 2 |
|
|
2021
Q3 | $139M | Buy |
2,356,000
+678,000
| +40% | +$40.1M | 2.36% | 2 |
|
|
2021
Q2 | $112M | Buy |
1,678,000
+178,000
| +12% | +$11.9M | 2.01% | 4 |
|
|
2021
Q1 | $94.7M | Buy |
1,500,000
+464,000
| +45% | +$29.3M | 2.17% | 2 |
|
|
2020
Q4 | $64.3M | Buy |
1,036,000
+36,000
| +4% | +$2.23M | 2.19% | 5 |
|
|
2020
Q3 | $60.3M | Hold |
1,000,000
| – | – | 2.19% | 6 |
|
|
2020
Q2 | $58.8M | Buy |
1,000,000
+352,000
| +54% | +$20.7M | 2.58% | 3 |
|
|
2020
Q1 | $36.1M | Buy |
648,000
+148,000
| +30% | +$8.25M | 2.23% | 10 |
|
|
2019
Q4 | $32.1M | Buy |
+500,000
| New | +$32.1M | 1.85% | 10 |
|